Phase
Condition
Dry Eyes
Eyelid Inflammation
Sjogren's Syndrome
Treatment
0.09% cyclosporine A ophthalmic solution
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Over 18 years of age.
Ocular Surface Disease Index score >= 23.
Strip meniscometry < 5 mm.
Exclusion
Exclusion Criteria:
Contact lens wearers.
Have corneal neuropathic or neurotrophic disease.
Have an ocular or medical condition or taking medications that could confound astudy outcome.
Currently pregnant or breastfeeding (cyclosporine is a FDA pregnancy Category Cdrug).
Have an ocular or medical condition for which Cequa is contraindicated (e.g.,allergy to cyclosporine or other ingredients in Cequacurrent eye infection, canceror precancerous condition in or around the eyes).
Have an allergy to fluorescein.
Study Design
Connect with a study center
University of Waterloo
Waterloo, Ontario N2J 3G1
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.